Home Authors Posts by Dr. Marie Gabrielle Laguna

Dr. Marie Gabrielle Laguna

756 POSTS 0 COMMENTS

Medical doctor-internist

https://www.eternusglobal.com

Asthma can be Diagnosed By A Simple Asthma Saliva Test

Dec 4, 2016

3785

A simple asthma saliva test which can diagnose asthma from an affected person’s saliva has been advanced through Loughborough University.

Around 5.4 million people are currently treated for bronchial asthma within UK, of which 1.1 million are kids.

To diagnose the situation medical doctors generally measure a person’s airflow lung potential, however lung function tests can be misguided and do not replicate underlying changes associated with allergies. Different checks, inclusive of blood, urine or sputum analysis can be distressing, especially for more youthful patients.

The new test created in collaboration with Nottingham City, is absolutely painless and gives a single-step diagnosis appropriate for humans of every age.

The Wonders of Saliva in Asthmatics

To develop this test, the research team, led by Professor Colin Creaser from Loughborough’s Department of Chemistry and Dr Dominick Shaw from the Respiratory Research Unit at City Hospital, accumulated saliva from patients with bronchial asthma and healthy people. They then carried out liquid chromatography-mass spectrometry (LC-MS) evaluation on the samples to find metabolic biomarkers.

With the aid of detecting the presence and amount of those ‘metabolic biomarkers’ the study can diagnose allergies. It also has the potential to pinpoint the severity and development of the ailment. Professor Creaser added, Unlike other sampling methods, such as expired breath analysis, saliva can be collected by passive drool from the very young to the very old without causing distress. We were therefore interested to know if techniques for metabolic profiling of saliva to identify physiological stress from exercise — developed by Loughborough — could be applied to asthma diagnosis. We were very excited to discover that they could.�

Before this new test can move to a medical setting the diagnostic metabolic biomarkers diagnosed the need to be demonstrated in further longitudinal research. If that is a success, the technique may be used in early asthma diagnosis as well as part of the ongoing tracking of patients. The studies have been posted in the magazine Analytical techniques.

A One-Dose Antibiotic Gel For Ear Infections

Dec 3, 2016

2342

A single-application bioengineered antibiotic gel which is squirted into the ear canal, may want to deliver a complete direction of antibiotic therapy for middle ear infections, making this remedy less complicated and potentially more effective. This was discovered by researchers from the Boston Children’s Hospital in collaboration with investigators at Boston Medical Center and Massachusetts Eye and Ear. The findings were published September 14 by the journal Science Translational Medicine.

Middle-ear infections, or otitis media, affect 95 percent of youngsters, prompting 12 to 16 million clinical visits every year within the U.S. It’s the number one reason for pediatric antibiotic prescriptions, but as parents realize, getting oral antibiotics into young children several times a day for 7 to 10 days is a frightening undertaking. According to Daniel Kohane, MD, PhD, the study’s senior investigator and director of the Laboratory for Biomaterials and Drug Delivery at Boston Children’s Hospital, Force-feeding antibiotics to a toddler by mouth is like a full-contact martial art.�

Youngsters also seem to get better within some days, so parents often stop remedy too quickly. Incomplete treatment and frequent recurrence of otitis media (40% of kids have four or more episodes) encourage the development of drug-resistant infections. And due to the fact that excessive doses had to get sufficient antibiotic to the ear, side outcomes like diarrhea, rashes and oral thrush are a commonplace. According to Rong Yang, PhD, a chemical engineer in Kohane’s lab and first author on the paper, With oral antibiotics, you have to treat the entire body repeatedly just to get to the middle ear. With the gel, a pediatrician could administer the entire antibiotic course all at once, and only where it’s needed.

Good Eardrum Penetration

Squirted into the ear canal, the gel quick hardens and remains in location, regularly dishing out antibiotics throughout the eardrum into the center ear. “Our technology gets matters across the eardrum that doesn't normally get across, in sufficient quantity to be therapeutic,” says Kohane.

Formerly, the eardrum (additionally called the tympanic membrane) was an impenetrable barrier. The bioengineered gel receives medicines past it with the assistance of chemical permeation enhancers (CPEs), compounds that are FDA-authorized for other uses which might be structurally similar to the lipids inside the stratum corneum, the eardrum’s outermost layer. The CPEs insert themselves into the membrane, starting up molecular pores that allow the antibiotics to seep through.

When examined in chinchillas (rodents with a hearing range and ear shape much like those of humans), the gel allotted high concentrations of the antibiotic ciprofloxin within the middle ear and absolutely cured ear infections due to Haemophilus influenzae in 10 of 10 animals. Regular ciprofloxacin ear drops cleared the contamination in just 5 of 8 animals after 1 week.

There was no observable toxicity, and no antibiotic became detected in the animals’ blood. Yang and Kohane determined a mild hearing loss, similar to that resulting from earwax. Giving less of the gel alleviated the trouble. Stephen Pelton, MD, a pediatric infectious disease physician at Boston Medical Center and a coauthor on the paper remarked, Transtympanic delivery of antibiotics to the middle ear has the potential to enable children to benefit from the rapid antibacterial activity of antimicrobial agents without systemic exposure and could reduce emergence of resistant microbes.�

Mobile App Beat2Phone Can Detect Irregular Heartbeats and Prevent Stroke

Dec 2, 2016

1864

VTT Technical Research Centre of Finland has developed a mobile app and a thumb-size tool called Beat2Phone that can help save you stroke in the form of cerebral infarctions at an early stage, throughout asymptomatic irregular heart rhythm or atrial fibrillation. The mobile device, which detects arrhythmia (abnormal heartbeat) has been tested with splendid results for two years in real-life situations in cooperation with people from Turku University Central Hospital.

An irregular heartbeat has a tendency to remain undiagnosed, if no symptoms are detected at some stage in Holter monitoring of heart rate and rhythm. Timo Varpula, Principal Scientist at VTT remarked, With the mobile device developed by VTT, users can register their ECG signal whenever arrhythmia or other heart symptoms occur. The device is also suitable for pre- and post-surgery monitoring of heart patients at home. There is no need for patients to visit a hospital, because the data is sent automatically from a mobile phone to medical staff via a cloud service�.

Arrhythmia Notifications Immediately In Your Cellphone

Handy and smooth to use, Beat2Phone appropriately measures the user’s heart rate and heart rate variability as a way to detect not only an abnormal heartbeat, but additionally overburdening and extended pressure. A high resting heart rate and low heart rate variability are indicators of pressure.

The Android app and device measure ECG alerts at a totally excessive sampling rate, becoming aware of individual heart beats and measure the interval between consecutive beats. The tool additionally includes activity and position sensors. It has a flexible strap that make Beat2Phone comfortable to put on.

The mobile device has been used by heart patients at Turku University Central Hospital, in addition to top athletes with heart conditions, who have been tremendously happy with it. Pinnacle athletes and professional sportspersons must monitor their heart activity often, because changes in ECG can be an indicator of myocarditis or different serious conditions.

The device has so far been tested by around 30 users, some of whom have also worn the device at night. The test users are people who’ve stated heart signs, but who have not had signs and symptoms at some stage in advanced Holter tracking.

In these tests, the device helped determine atrial fibrillation, arrhythmia and a cardiac conduction ailment. The sufferers were admitted for further checks when they had shown their Beat2Phone electrocardiograms to a health practitioner. People who have harmless abnormal heartbeats have additionally mentioned a good quality of life because of the measuring device alleviating their uncertainty regarding their medical condition. The research is still ongoing.

Other potential users of the tool consist of people with sleep apnea. The tool is anticipated to go on sale to consumers in six months’ time.

Wound Healing with Cold Plasma Therapy

Nov 27, 2016

2191

Russian scientists on the Moscow Institute of Physics and Technology (MIPT), the Joint Institute For High Temperatures of the Russian Academy of Sciences (JIHT RAS), and Gamaleya studies Centre of Epidemiology and Microbiology determined that treating cells with cold plasma therapy results in their regeneration and rejuvenation. This result can be used to develop a plasma therapy method for sufferers with non-healing wounds. The paper has been posted in the journal of Physics D: Applied Physics.

Non-healing wounds make it hard to offer powerful remedies to patients and are consequently a serious problem confronted by health practitioners. These wounds can be resulting from damage to blood vessels in the case of diabetes, failure of the immune system attributable to HIV infection or cancers, or sluggish cell divisions in elderly people. Treatment of non-healing wounds by way of conventional methods is very tough and in some cases impossible.

Cold atmospheric-pressure plasma refers to a partially ionized gas with a temperature below 100,000 k. Its use in biology and medicine has been made feasible by means of the appearance of plasma sources generating jets at 30-40�C.

An earlier study has found out the bactericidal properties of cold plasma, in addition to the noticeably high resistance of cells and tissues to its effects. The consequences of plasma therapy of patients with non-healing wounds are oftentimes positive to neutral. The authors’ previous work caused them to research the possibility that the impact of plasma treatment on wound recuperation should depend upon how it is being applied.

There are two types of cells that have been used in this study: fibroblasts (connective tissue cells) and keratinocytes (epithelial cells). Each play a critical position in wound recovery.

The effect of plasma treatment on cells was evaluated. In fibroblast samples, the quantity of cells increased by 42.6% after one application (A) and by 32% after two applications (B), in comparison to the untreated controls. While no DNA breaks had been detected following plasma application, an accumulation of cells inside the active stages of the cell cycle was determined, along with an extended growth phase (30 hours), which means that the impact of plasma could be characterized as regenerative.

The proliferation of cells that were treated everyday over a period of 3 days (group C) was reduced to 29.1% relative to the controls. Keratinocytes did no longer display significant changes in proliferation.

The researchers also carried out an assay of the senescence-related ?-galactosidase that was measured at pH 6.0. The concentration of this enzyme in a cell increases with age. Plasma treatment notably decreased the content of this substance inside the samples. This, together with a prolonged exponential boom section of the way of life, indicates a practical activation of cells — their rejuvenation.

According to Elena Petersen, a co-author of the paper and the head of the Laboratory of Cellular and Molecular Technologies at MIPT, ’The positive response to plasma treatment that we observed could be linked to the activation of a natural destructive mechanism called autophagy, which removes damaged organelles from the cell and reactivates cellular metabolic processes.�

The scientists are planning additional studies into the molecular mechanisms underlying the effects of plasma on cells. Additionally they want to decide the effects of an affected person’s age on the effectiveness of plasma therapy.

JAK Inhibitors Drugs Restores Hair Growth in Patchy Hair Loss

Nov 24, 2016

3185

Around 75 percent of sufferers with slight to extreme alopecia areata, an autoimmune disease that reasons patchy, and much less regularly, overall hair loss, had tremendous hair regrowth after treating with ruxolitinib (JAK inhibitors), stated researchers from Columbia University Medical Center (CUMC). By the end of their treatment, average hair regrowth became 92 %.

Findings from an open-label clinical trial of 12 patients with alopecia areata have been posted in the Journal of Clinical INvestigatio/Insight, alongside a paper reporting results of a separate study from Stanford university and Yale university that examined a comparable drug.

Julian Mackay-Wiggan, MD, MS, associate professor and director of the clinical research unit in dermatology at CUMC and a dermatologist at NewYork-Presbyterian/Columbia remarked, Although our study was small, it provides crucial evidence that JAK inhibitors may constitute the first effective treatment for people with alopecia areata. This is encouraging news for patients who are coping with the physical and emotional effects of this disfiguring autoimmune disease.�

Alopecia Areata and The Immune System

Alopecia areata, the second most common type of hair loss, can arise at any age and affects women and men equally. The disorder commonly causes hair loss on the scalp, but some patients also revel in facial and body hair loss, with devastating effects especially in kids. Currently, there aren’t any recognized remedies that could completely repair hair loss.

Formerly, the Columbia researchers diagnosed the specific immune cells and the dominant inflammatory signaling pathways responsible for attacking the hair follicle in alopecia areata, setting them right into a dormant state. Subsequent experiments with mouse and human hair follicles confirmed that topical and oral medicines that inhibit the Janus kinase (JAK) family of enzymes, called JAK inhibitors, reawaken those dormant follicles via blockading inflammatory signaling.� Such JAK inhibitors are already approved by the U.S. FDA such as ruxolitinib, a medicine this is used to deal with bone marrow malignancies, and tofacitinib, a remedy for rheumatoid arthritis.

According to Raphael Clynes, MD, PhD, adjunct associate professor of dermatology at CUMC, These disorders are both characterized by dysregulated signaling pathways, similar to alopecia areata, which is dominated by the interferon signaling pathway. Even though the diseases are very different, this common feature gave us the initial idea to test JAK inhibitors in people with alopecia.�

To test this speculation, the researchers initiated a small, open-label clinical trial of 12 sufferers with moderate to excessive alopecia areata (greater than 30 percentage hair loss). All sufferers have been given 20 mg of oral ruxolitinib, twice a day, for 3 to 6 months. Members have been followed for a further three months to assess the durability of remedy response.

Nine of the patients had hair regrowth of 50 percent or more. By the end of the treatment period, 77% of those who responded to the therapy had hair regrowth of over 95%. A third of the responders had great hair loss within the follow-up period after the medication was stopped, although their hair loss did not reach pre-remedy levels.

Skin biopsies performed before, throughout, and after remedy also revealed that responders had a decrease in stages of interferon signaling and cytotoxic T lymphocytes, which are indicators of an inflammatory reaction, and better ranges of hair keratins, which are proteins that imply hair growth. Those degrees were much like those in people without alopecia areata. Before starting treatment, patients who in the long run did no longer respond to remedy had lower ranges of inflammatory signatures, suggesting that it can be possible to differentiate among responders and nonresponders.

According to Angela M. Christiano, PhD, the Richard and Mildred Rhodebeck Professor of Dermatology and professor of genetics and development at CUMC, We are very excited about the use of biomarkers to follow the response of patients to this treatment. This will allow us to so monitor improvements in their gene expression signatures even before hair growth appears.�

The drug was tolerated in all subjects, and had no serious adverse reactions. Those which did occur were infrequent, and were in the form of bacterial skin infections, skin allergic reaction signs and symptoms, and lower hemoglobin stages, which resolved with dose adjustment.

Dr. Mackay-Wiggan further remarked, Our findings suggest that initial treatment induces a high rate of disease remissions in patients with moderate to severe alopecia areata but maintenance therapy may be needed. While larger, randomized trials are needed to confirm the safety and efficacy of ruxolitinib in people with moderate to severe alopecia areata, our initial results are very encouraging.�

Autistic Children Can Benefit From Folinic Acid

Nov 16, 2016

2041

Prescription doses of folinic acid, a reduced form of a B vitamin also known as folate, could support the language and communication of kids with autism spectrum disorder (ASD). These are the preliminary findings from a placebo-managed trial where youngsters had been randomized to receive both high-dose folinic acid or a placebo, says lead author Richard Frye of Arkansas Children’s Research Institute in the US. The study, which is published in Springer Nature’s journal Molecular Psychiatry, also identified a particular blood marker that can be utilized to foretell which patients have the best response to therapy.

Up to 2 percent of youngsters are said to experience symptoms that position them on the autism spectrum. Many of these kids have trouble speaking and interacting with others, especially in social surroundings. Researchers do not yet fully grasp all of the causes of ASD and, importantly, there are currently no authorised cures that deal with the symptoms of this disorder. John Slattery, a co-author of the study said, The only currently approved medications for autism are both antipsychotic medications that address non-core symptoms and can lead to unwanted side effects.�

Folinic Acid

Scientific studies have linked this sickness to abnormalities within the metabolism of folate as good as genes which can be involved in folate metabolism. Distinctive reviews have also proven that the children of females who took folate supplements before conception and throughout being pregnant had a lesser chance of bearing a child with ASD.

About ten years ago cerebral folate deficiency (CFD) used to be described as a condition wherein folate is beneath normal levels in the central nervous system however not in the blood. Many kids with CFD had ASD signs and responded well to treatment with high-dose folinic acid.

Previously, Frye’s group have exhibited that folate receptor autoantibodies have been found with an excessive prevalence in youngsters with ASD. Within the present study, these researchers discovered that participants with folate receptor autoantibodies had beneficial response to the folinic acid treatment. This leads to a test that is probably necessary for clinicians to determine if high-dose folinic acid may be a treatment for a youngster with ASD. The deleterious effects of folate receptor antibodies on the brain growth and function are actually proven in a laboratory rat model.

Frye said, Improvement in verbal communication was significantly greater in participants receiving folinic acid as compared with those receiving the placebo.� He remarks that the findings must be considered preliminary unless the treatment has been assessed more in larger lengthy-time period reports.

The researchers indicated they were very happy with the positive findings of this study, but they are warning that more research is needed in order to replicate the findings in a greater population.

Cell Aging Genes Identified; Holds Potential For Cancer Treatment

Nov 15, 2016

1575

A study group that includes KAMADA Shinji, Research Fellow NAGANO Taiki (both from the Kobe University Biosignal Research Center), and Unit Chief ENARI Masato (National Cancer Research Institute) has succeeded in figuring out cell aging genes that manage cell senescence — completely arrested cell growth. The procedure treated liver cancer cells with anticancer medicines of diverse concentrations, inducing apoptotic cellular dying and cell senescence, and comparing gene expression tiers.

By developing medicines that suppress the activities of these genes, this discovery can lead to the production of effective anticancer medicines, or use in anti-aging medicine. The outcomes of this research were published on August 22 inside the online version of Scientific Reports.

Living things often experience diverse stresses for the duration of their lifespans. These stresses encompass radiation, ultraviolet rays, and chemical substances that directly damage DNA and cause most cancers. Organisms are able to rapidly repair DNA while it is damaged, but while the damage is extreme, they exhibit two extraordinary cell responses: apoptosis — a kind of managed cellular demise — and cell senescence, which completely suspends cell increase. Each those responses prevent the damaged cells from proliferating and becoming cancerous.

Cancer remedies primarily are based on radiation and anticancer medicines target to wreck cancer tissue through triggering apoptosis in cancerous cells. But, this treatment is itself a strain element that induces cell mutation, causing modifications inside the cancerous cells. These cells produce clones that have received resistance towards the treatment, leading to relapse. One of the changes in cancerous cells resulting from this treatment is the arrival of senescent cells. It has been recommended that by means of secreting various proteins, senescent cells may additionally accelerate the proliferation and malignant transformation of surrounding cancer cells.

Cell Genes in Senesence

The study group had formerly found that cellular senescence was successfully caused by using low concentrations of anticancer medicines on cancerous cells. In anticancer remedy, medicines are carried to the cancerous tissue via the bloodstream. The researchers predicted that differences in concentrations of the anticancer medicines could rise up based totally on the space of the cells from the blood vessels, and so even in the ordinary cancer treatment process senescent cells could emerge. Consequently, if we simultaneously administer a medication that inhibits cell senescence at some point of cancer remedy, there is the ability for a dramatic growth in remedy effectiveness.

Formerly the study group observed that if cancerous cells are handled with a low concentration (10 ?M) of the anticancer drug etoposide this induces cellular senescence, and if they’re dealt with a excessive concentration of the drug (100 ?M) this induces apoptosis. For this study, they handled cancerous cells under 3 distinctive situations: A) without etoposide; B) with a low dose of etoposide (10 ?M); and C) with a high dose of etoposide (100 ?M). They then used DNA microarrays to become aware of the genes in which a rise in transcription ranges could be located.

They anticipated that genes which confirmed elevated expression in response to treatment B have been especially related to cell senescence, genes expressed in reaction to C had been in particular those involved in apoptosis, and the various genes which specially confirmed improved expression in B as compared to C could be genes that play an essential function in implementing cellular senescence.

There were 126 genes where thrice as much expression was recorded below treatment B as compared to A, and 25 genes that confirmed two times as much expression in B in comparison to C. These 25 genes are predicted to show in senescent cells because the alternative elements as a result of DNA damage are removed, and researchers showed that the genes concerned in inflicting cell senescence had been amongst them.

If we will develop a drug that targets and regulates the interest of the genes that control senescence identified in this research, by administering it collectively with conventional anticancer treatment we are able to restrict the emergence of senescent cells and probably increase the effectiveness of most cancer treatments. Additionally, it has been pronounced that one of the causes of ageing is the accumulation of senescent cells. This means that medicines which control cell senescence should have doubtlessly huge advantages on the improvement of anti-ageing treatments associated with fitness and beauty.

Cannabis Can be Harmful, Study Shows

Nov 14, 2016

2030

Researchers have clarified critical mechanisms involved with the formation of neural circuits in the brain. This organization also discovered that delta-nine-tetrahydrocannabinol (THC), a psychoactive substance also found in hashish or cannabis, causes disruption of neural circuits inside the cortex. Those consequences provide an explanation for why cannabis may be dangerous and have capacity to find application in the purposeful restoration of brain damage and in instances of dementia.

Neural interest is thought to play a vital function inside the formation of neural circuits. However, we still do no longer realize what kind of neural activities are concerned in this formation procedure. This manner is mainly complex in projections from the thalamus to the cortex, of which thus far we knew that as these projections expand, unnecessary projections are removed, thereby leaving the most effective projections. A group of researchers led by Fumitaka Kimura, associate professor at the Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University, has now clarified the involvement of numerous mechanisms within the formation of this neural circuit. The researchers also found scientific proof that cannabis intake causing the trimming of neural connections, leading to a breakdown of neural circuits.

Harmful Cannabis

In this study, the researchers determined that in a different section of the cortex, the rule (Spike Timing-Dependent Plasticity: STDP) by using synaptic electricity (a purposeful measure of connections) between neurons become determined all at once changed at a positive point in improvement. Based on this finding, the group tested whether or not a similar STDP change occurred in the projection from the thalamus and the cortex as well. They determined that to begin with, the synapses were strengthened due to the synchronized activities of the pre- (thalamic) and post- (cortical) synaptic neurons. But after the projections had spread widely, the synchronized activities weakened all but a few synapses, thereby doing away with projections to allow more systematic ones. As the synapses are weakened, endogenous cannabinoid is released from nerve cells via those synchronized activities, leading to a regression of unnecessary neuron projections. The researchers also showed that such regression while cannabinoid is taken in externally.

Those findings might have an effect on future research targeted on advancing our understanding of the mechanisms involved within the formation of neural circuits and feature the capability to cause the development of recent treatment options to enhance recuperation from brain damage and dementia. Further, the findings provide medical evidence for the detrimental outcomes of cannabis intake on brain improvement and consequently may also help to lower abuse of marijuana.

This study was featured within the digital version of the Journal of Neuroscience on June 29, 2016.

Hand Function After Stroke Is Improved By Electrical Stiimulation

Nov 13, 2016

2623

A new electrical stimulation remedy helped stroke survivors with hand weakness improve hand dexterity greater than an existing stimulation approach, in line with new studies in the American Heart Association’s journal Stroke.

Approximately 800,000 people within the United States of America have strokes every year, according to the American Heart Association. Stroke generally results in some paralysis or partial paralysis on one side of the body that can result in survivors having difficulties in executing function. A common remedy in stroke rehabilitation uses low tiers of electrical current to stimulate the paralyzed muscle groups to open the hand, enhance muscle power and likely repair hand function. Stimulation intensity, cycle timing, and repetitions are set by a therapist.

Electrical Stimulation

In the new experimental therapy discovered by researchers at the MetroHealth System, Case Western Reserve University and the Cleveland Functional Electrical Stimulation Center, sufferers manage the stimulation to their vulnerable hand by wearing a glove with sensors on the opposite, unaffected hand. When the affected person opens their unaffected hand, they receive a corresponding amount of stimulation that opens their susceptible stroke-affected hand. This places the affected person in control of their hand and permits them to participate in therapy with the help of electrical stimulation.

According to Jayme S. Knutson, Ph.D., senior author of the study and an assistant professor of Physical Medicine and Rehabilitation at Case Western Reserve University School of Medicine in Cleveland, Ohio, Based on positive findings from our previous studies, we sought to determine if the new glove-controlled hand stimulation therapy could be more effective than the common therapy in improving hand dexterity in patients who are more than six months past their stroke.�

Researchers enrolled 80 stroke survivors. For 12 weeks, half of the survivors received remedy using the new glove, and the remainder received the common remedy. Both groups used an electrical stimulator on their own at home for 10 hours every week, plus three hours per week training hand tasks with an occupational therapist in the lab. Hand feature was measured earlier and after remedy with a standard dexterity test that measured the number of blocks members can pick out up, elevate over a barrier and launch in some other place on a desk within a 60 second duration. They determined that sufferers who acquired the new therapy had extra improvement at the dexterity test (4.6 blocks) than the common institution (1.8 blocks). Patients who had greater improvements in hand dexterity following the new therapy have been much less than two years post-stroke and had at least a few finger movements when they started the study. These sufferers saw a development of 9.6 blocks on the dexterity test, compared to 4.1 blocks in the common group.

Sufferers without a finger movement additionally noticed upgrades in arm movement after the new remedy. At the end of treatment, 97 percent of the subjects who obtained the new therapy agreed that they might use their hand greatly than on the start of the study.

Due to the fact that the therapy is new and this was a single-site study, researchers do not know if similar outcomes may also be seen in other rehab centers. They plan to perform a multi-site study to verify their consequences, as well as measure quality of life enhancements for sufferers. And whilst the researchers speculate that the new remedy can be converting neural connections within the brain that manage hand dexterity, extra research is yet to prove what consequences it is able to have on the central nervous system.

The study additionally demonstrates that stroke sufferers can correctly use technology for self-administered therapy at home. According to Knutson, Home-based therapy is becoming increasingly important to offset increasing healthcare costs and to meet the need for high doses of therapy that are critical for attaining the best outcomes. The more therapy a patient can get the better potential outcome they will get.�

Vitamin A Can Help Treat Pancreatic Cancer

Nov 12, 2016

2128

Scientists suggest that vitamin A may additionally have a position to play in tackling the commonest form of pancreatic cancer.

Pancreatic ductal adenocarcinoma (PDAC), the most common of all pancreas cancer types, is extraordinarily competitive and very difficult to treat. Many scientists are currently investigating the genetic mutations and biochemical signalling pathways that enable most cancers cells to unfold to other body areas.

Vitamin A and Pancreatic Cancer

In a new study published in Nature Communications, researchers from Imperial College London have taken a distinct method on the usage of cells inside the lab. They have investigated how mechanical changes in a collection of cells living within the immediate environment of the tumour, known as stellate cells, have an effect on the progression of PDAC. According to Dr Armando del Rio Hernandez, from the Department of Bioengineering at Imperial, The survival rate of pancreatic cancer has remained relatively unchanged during the last 40 years, despite advances in conventional therapies targeting cancer cells. We’ve changed the focus from cancer cells to the cells that surround the tumour. We’ve combined traditional approaches to cancer biology with understanding the mechanics behind the progression of tumours. This could meet a pressing unmet clinical need in the UK and worldwide.�

In a healthy pancreas, stellate cells exist as dormant, storing considerable supplies of vitamin A. But, as PDAC progresses, these stellate cells are activated in response to signals from the tumour, and lose their vitamin A content.

Activated stellate cells form a dense connective tissue around the tumour, that is used by most cancers cells to spread to other areas of the body. The tissue also limits the ability of most cancers-preventing medicines to reach the tumour.

In this new study, the researchers found out that it was okay to interchange pancreatic stellate cells, potentially stopping the formation of the tissue around the tumour, via a process concerning vitamin A.

In a healthy body, vitamin A is transformed into All-Trans-Retinoic Acid (ATRA), which enables adjustment of a couple of capabilities such as ordinary growth and development. While the researchers induced this method in cells inside the laboratory, ATRA switched off the forces that the stellate cells used to rework their surroundings. This decreased the fibrosis and also produced surroundings wherein it would be more hard for a pancreatic tumour to unfold.

The researchers cautioned that the study looked at the behaviour of cells within the laboratory and they do not have evidence that patients might gain from taking dietary supplements of vitamin A. Similarly further research is wanted including clinical trials. However, they accept that their new insights into the mechanisms of PDAC will help scientists to explore new possibilities for tackling the sickness.

According to Mr Antonios Chronopoulos, a postgraduate from the Department of Bioengineering at Imperial and co-author of the study, Other research groups in the past have explored the idea of destroying the fibrotic tissue and stellate cells altogether to weaken the tumour. Our approach is much more subtle. Instead of destroying them, we simply want to revert the chronically activated stellate cells to a dormant state in an attempt to reduce fibrosis and reprogram the tumour microenvironment to a healthy state, thus suppressing the signals that spur cancer growth.�

Prev 1...343536...76 Next

Page 35 of 76